Climate change and disorders of the nervous system
- PMID: 38760101
- DOI: 10.1016/S1474-4422(24)00087-5
Climate change and disorders of the nervous system
Abstract
Anthropogenic climate change is affecting people's health, including those with neurological and psychiatric diseases. Currently, making inferences about the effect of climate change on neurological and psychiatric diseases is challenging because of an overall sparsity of data, differing study methods, paucity of detail regarding disease subtypes, little consideration of the effect of individual and population genetics, and widely differing geographical locations with the potential for regional influences. However, evidence suggests that the incidence, prevalence, and severity of many nervous system conditions (eg, stroke, neurological infections, and some mental health disorders) can be affected by climate change. The data show broad and complex adverse effects, especially of temperature extremes to which people are unaccustomed and wide diurnal temperature fluctuations. Protective measures might be possible through local forecasting. Few studies project the future effects of climate change on brain health, hindering policy developments. Robust studies on the threats from changing climate for people who have, or are at risk of developing, disorders of the nervous system are urgently needed.
Copyright © 2024 Elsevier Ltd. All rights reserved, including those for text and data mining, AI training, and similar technologies.
Conflict of interest statement
Declaration of interests HMo chairs Dyson's Scientific Advisory Board and the Lancet Countdown on Health and Climate Change; holds a patent relating to a means to improve patient hydration in hospitals; is a member of the UK Climate and Health Council; is a cofounder of Real Zero (a non-profit company helping decarbonise health care); and has received honoraria for talks on climate change, but none for talks related to the topic of this Personal View. NCF is the member of the Research Strategy Council of Alzheimer's Society (UK). DJW has received grant funding from the Stroke Association and British Heart Foundation; speaking honoraria from Bayer; speaking and chairing honoraria from Alexion and NovoNordisk; and consultancy fees from Alnylam, Bayer, and NovoNordisk. DW has also participated on a data safety monitoring board for OXHARP, and the TICH-3, RESTART, MACE-ICH, and PLINTH Trial Steering Committees. MAK has received payments from Bloomsbury Genetic Therapies and PTC; holds shares in Bloomsbury Genetic Therapies (unrelated to this work as involvement pertains to the development of gene therapies for rare neurometabolic disorders); has leadership or fiduciary role in LifeArc grants committee (not relevant to this work as this membership pertains to the review of grants and allocation of funding through the Philanthropic fund); is the theme lead for the National Institute for Health Research Great Ormond Street Hospital Biomedical Research Centre Accelerating Novel Therapies; and has patents, issued or pending, for DTDS viral vector. OC reports speaking honoraria from Merck and Biogen and for participation on a data safety monitoring board for Novartis. MM has grants or contracts from Ehlers Danlos Society, Abbott, and Medtronic; reports consulting fees from AbbVie, Kriya, TEVA, Lundbeck, Eli Lilly, Salvia, and Pfizer, all paid to their institution; reports payment or honoraria for lectures, presentations, speakers bureaux, manuscript writing, or educational events from AbbVie, Pfizer, and Eli Lilly; reports patents (planned, issued, or pending) for WO2018051103A1: System and method for diagnosing and treating headaches; and is the president of the medical advisory board of CSF Leak Association and a board member of the Anglo Dutch Migraine Association. All other authors declare no competing interests.
Similar articles
-
Imperatives and co-benefits of research into climate change and neurological disease.Nat Rev Neurol. 2025 Apr;21(4):216-228. doi: 10.1038/s41582-024-01055-6. Epub 2025 Jan 20. Nat Rev Neurol. 2025. PMID: 39833457 Review.
-
The 2023 Latin America report of the Lancet Countdown on health and climate change: the imperative for health-centred climate-resilient development.Lancet Reg Health Am. 2024 Apr 23;33:100746. doi: 10.1016/j.lana.2024.100746. eCollection 2024 May. Lancet Reg Health Am. 2024. PMID: 38800647 Free PMC article. Review.
-
Neurological disorders vis-à-vis climate change.Early Hum Dev. 2021 Apr;155:105217. doi: 10.1016/j.earlhumdev.2020.105217. Epub 2020 Oct 1. Early Hum Dev. 2021. PMID: 33069514 Review.
-
Health challenges of climate change in the Eastern Mediterranean and Middle East region, with a focus on Türkiye. An environmental neurological and brain health perspective.J Neurol Sci. 2025 Mar 15;470:123423. doi: 10.1016/j.jns.2025.123423. Epub 2025 Feb 10. J Neurol Sci. 2025. PMID: 39954572
-
How climate change degrades child health: A systematic review and meta-analysis.Sci Total Environ. 2024 Apr 10;920:170944. doi: 10.1016/j.scitotenv.2024.170944. Epub 2024 Feb 14. Sci Total Environ. 2024. PMID: 38360325
Cited by
-
Seasonal Variations in Multiple Sclerosis Relapses in Oman: A Single Tertiary Centre Experience.Int J Environ Res Public Health. 2024 Oct 17;21(10):1371. doi: 10.3390/ijerph21101371. Int J Environ Res Public Health. 2024. PMID: 39457344 Free PMC article.
-
The influence of temperature and genomic variation on intracranial EEG measures in people with epilepsy.Brain Commun. 2024 Sep 10;6(5):fcae269. doi: 10.1093/braincomms/fcae269. eCollection 2024. Brain Commun. 2024. PMID: 39258258 Free PMC article.
-
Imperatives and co-benefits of research into climate change and neurological disease.Nat Rev Neurol. 2025 Apr;21(4):216-228. doi: 10.1038/s41582-024-01055-6. Epub 2025 Jan 20. Nat Rev Neurol. 2025. PMID: 39833457 Review.
-
Medications, epilepsy and climate change: Added layers of complexity.Br J Clin Pharmacol. 2025 Aug;91(8):2205-2221. doi: 10.1002/bcp.70108. Epub 2025 May 27. Br J Clin Pharmacol. 2025. PMID: 40432167 Free PMC article. Review.
-
Understanding the health impacts of the climate crisis.Future Healthc J. 2025 Mar 31;12(1):100240. doi: 10.1016/j.fhj.2025.100240. eCollection 2025 Mar. Future Healthc J. 2025. PMID: 40236934 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical